News

 
News Brief

Problem Solving Around Access to Medications to Treat OUD During the COVID-19 Pandemic

March 25, 2020
As part of our ongoing support of those in need amidst the COVID-19 pandemic, JBS subject experts provided guidance for patients and providers of opioid agonist therapy who face unique challenges at this time. This JBS News Brief addresses the following topics and is part of our dedication to helping real people make real progress:
  • Social Distancing in OTPs
  • OTP Patients and Self-Quarantine
  • Telehealth and Buprenorphine Maintenance in the Office-Based Setting 
  • Problem Solving Around Access to Medications to Treat OUD During the COVID-19 Pandemic

Doing Business with JBS

If your organization aims to improve lives and make the world a better place, we want to work with you.

View Our Clients